207 related articles for article (PubMed ID: 29606309)
1. Targeting Biophysical Cues: a Niche Approach to Study, Diagnose, and Treat Cancer.
Zhang SX; Liu L; Zhao W
Trends Cancer; 2018 Apr; 4(4):268-271. PubMed ID: 29606309
[TBL] [Abstract][Full Text] [Related]
2. Transport Barriers and Oncophysics in Cancer Treatment.
Nizzero S; Ziemys A; Ferrari M
Trends Cancer; 2018 Apr; 4(4):277-280. PubMed ID: 29606312
[TBL] [Abstract][Full Text] [Related]
3. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
Stylianopoulos T; Munn LL; Jain RK
Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment and systemic disease: a dual target in medical oncology (also in the case of biomarkers).
Melichar B
Clin Chem Lab Med; 2017 Oct; 55(12):1813-1816. PubMed ID: 29040065
[No Abstract] [Full Text] [Related]
5. Engineered bifunctional proteins and stem cells: next generation of targeted cancer therapeutics.
Choi SH; Shah K
Discov Med; 2016 Sep; 22(120):157-166. PubMed ID: 27755970
[TBL] [Abstract][Full Text] [Related]
6. Invasive leader cells: metastatic oncotarget.
Cheung KJ; Ewald AJ
Oncotarget; 2014 Mar; 5(6):1390-1. PubMed ID: 24727787
[No Abstract] [Full Text] [Related]
7. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
8. Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer.
Anari F; Ramamurthy C; Zibelman M
Future Oncol; 2018 Jun; 14(14):1409-1421. PubMed ID: 29848096
[TBL] [Abstract][Full Text] [Related]
9. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
Crupi MJF; Bell JC; Singaravelu R
Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
[TBL] [Abstract][Full Text] [Related]
10. Phagocyte-extracellular matrix crosstalk empowers tumor development and dissemination.
Varol C; Sagi I
FEBS J; 2018 Feb; 285(4):734-751. PubMed ID: 29106767
[TBL] [Abstract][Full Text] [Related]
11. Oncology biomarkers--second annual GTCbio conference. Biomarkers for disease detection and therapeutics monitoring. 19-20 January 2009, Miami, FL, USA.
Scholler N
IDrugs; 2009 Apr; 12(4):207-10. PubMed ID: 19350459
[No Abstract] [Full Text] [Related]
12. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
Zhang B; Cheng P
Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
[TBL] [Abstract][Full Text] [Related]
13. Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment.
Yano S; Tazawa H; Kishimoto H; Kagawa S; Fujiwara T; Hoffman RM
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477279
[TBL] [Abstract][Full Text] [Related]
14. Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics.
Patel H; Nilendu P; Jahagirdar D; Pal JK; Sharma NK
Cancer Biol Ther; 2018 Jan; 19(1):3-12. PubMed ID: 29219656
[TBL] [Abstract][Full Text] [Related]
15. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
Park GT; Choi KC
Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic Virotherapy and the Tumor Microenvironment.
Berkey SE; Thorne SH; Bartlett DL
Adv Exp Med Biol; 2017; 1036():157-172. PubMed ID: 29275471
[TBL] [Abstract][Full Text] [Related]
17. How Can We Treat Cancer Disease Not Cancer Cells?
Kim KW; Lee SJ; Kim WY; Seo JH; Lee HY
Cancer Res Treat; 2017 Jan; 49(1):1-9. PubMed ID: 28052653
[TBL] [Abstract][Full Text] [Related]
18. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Zhang Y; Ho SH; Li B; Nie G; Li S
Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
[TBL] [Abstract][Full Text] [Related]
19. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.
Fang H; Declerck YA
Cancer Res; 2013 Aug; 73(16):4965-77. PubMed ID: 23913938
[TBL] [Abstract][Full Text] [Related]
20. Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance.
Singh A; Brito I; Lammerding J
Trends Cancer; 2018 Apr; 4(4):281-291. PubMed ID: 29606313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
